1. Pathology Review for Patients with Prostate Cancer Referred to the SCCA Proton Center
- Author
-
George E. Laramore, Jing Zeng, Li-Ming Christine Fang, Jay J. Liao, and Kenneth J. Russell
- Subjects
Pathology ,medicine.medical_specialty ,Prostate cancer ,business.industry ,Risk stratification ,medicine ,Radiology, Nuclear Medicine and imaging ,Gleason scores ,Newly diagnosed ,medicine.disease ,business ,Atomic and Molecular Physics, and Optics - Abstract
Purpose: Treatment guidelines for patients with newly diagnosed prostate cancer are largely determined by risk stratification (low, intermediate, high), which is based upon 3 parameters: T-stage, prostate-specific antigen value, and Gleason score. The purpose of this report is to evaluate the results of a central review for patients with prostate cancer treated at the center during its first year of operation. Patients and Methods: Between March 13, 2013, and April 14, 2014, a total of 53 patients with prostate cancer, with Gleason scores initially determined by outside pathologists, were treated at the center. Tissue specimens were obtained for all patients and were reviewed by the Department of Pathology at the University of Washington. The results of this review were tabulated and analyzed. Results: The original Gleason score was confirmed in 42 cases. The original Gleason score was upgraded in 7 cases and downgraded in 4 cases. Four patients who were originally classified in a low-risk catego...
- Published
- 2015
- Full Text
- View/download PDF